Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01681212
Brief Title: Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma

First Submitted : September 5, 2012
First Submitted that Met QC Criteria : September 5, 2012
First Posted : September 7, 2012 (Estimate)

Results First Submitted : May 22, 2015
Results First Submitted that Met QC Criteria : June 9, 2015
Results First Posted : June 11, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 9, 2015
Last Update Posted : June 11, 2015 (Estimate)